6 Recruiting Follicular Lymphoma Clinical Trials in Massachusetts
Explore active follicular lymphoma research studies enrolling across Massachusetts. Verify eligibility and contact site coordinators.
📍 Find Near Me by DistanceBrowse by City
Recruiting Follicular Lymphoma Studies in Massachusetts
🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic
Glofit and Obin in Follicular Lymphoma and Marginal Zone Lymphoma
📍 Beth Israel Deaconess Medical Center — Boston, Massachusetts
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1 💊 Investigational Drug / Biologic
Personalized Neoantigen Cancer Vaccine + Pembrolizumab After Rituximab for Follicular Lymphoma
📍 Dana Farber Cancer Institute — Boston, Massachusetts
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2 💊 Investigational Drug / Biologic
A Novel Vaccine (EO2463) as Monotherapy and in Combination, for Treatment of Patients With Indolent Non-Hodgkin Lymphoma
📍 Dana Farber Cancer Institute — Boston, Massachusetts
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
Odronextamab in Low Tumor Volume Advanced FL
📍 Beth Israel Deaconess Medical Center — Boston, Massachusetts
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
Epco, Zanu, Ritux for R/R FL or MZL
📍 Dana-Farber Cancer Institute — Boston, Massachusetts
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
Epcoritamab and Rituximab for First-line Follicular Lymphoma
📍 Beth Israel Deaconess Medical Center — Boston, Massachusetts
View Study & Checklist ➔